R1	Has_value Arg1:T2 Arg2:T1	
*	OR T4 T3
R2	Has_mood Arg1:T5 Arg2:T4	
R3	Has_negation Arg1:T8 Arg2:T9	
R4	Has_temporal Arg1:T8 Arg2:T10	
R5	Has_value Arg1:T13 Arg2:T14	
R6	Has_value Arg1:T15 Arg2:T16	
*	OR T13 T15
R7	AND Arg1:T12 Arg2:T13	
R8	Has_multiplier Arg1:T12 Arg2:T11	
R9	Has_temporal Arg1:T7 Arg2:T18	
R10	Subsumes Arg1:T5 Arg2:T7	
R12	AND Arg1:T8 Arg2:T12	
*	OR T5 T8
R11	Has_qualifier Arg1:T27 Arg2:T26	
R13	Has_temporal Arg1:T27 Arg2:T28	
R14	Has_index Arg1:T28 Arg2:T29	
R15	Has_context Arg1:T23 Arg2:T27	
R16	Has_mood Arg1:T27 Arg2:T30	
*	OR T33 T34
R17	Has_qualifier Arg1:T34 Arg2:T35	
R18	Has_qualifier Arg1:T33 Arg2:T36	
R19	multi Arg1:T37 Arg2:T38	
R20	Has_value Arg1:T39 Arg2:T40	
R21	Subsumes Arg1:T40 Arg2:T41	
R22	multi Arg1:T43 Arg2:T44	
R23	multi Arg1:T45 Arg2:T44	
R24	Has_temporal Arg1:T43 Arg2:T42	
R25	Has_temporal Arg1:T43 Arg2:T46	
*	OR T37 T43
R26	Has_qualifier Arg1:T49 Arg2:T50	
R27	Has_context Arg1:T24 Arg2:T27	
R28	Has_temporal Arg1:T45 Arg2:T42	
R29	Has_temporal Arg1:T45 Arg2:T46	
*	OR T39 T43
T1	Value 3 13	= 45 years
T2	Person 14 17	old
T3	Temporal 38 46	previous
T4	Mood 25 34	diagnosis
T5	Condition 60 82	essential hypertension
T7	Drug 118 140	antihypertensive drugs
T8	Drug 174 196	antihypertensive drugs
T9	Negation 164 167	not
T10	Temporal 197 220	within the last 2 weeks
T11	Multiplier 222 237;266 288	two consecutive at least one day apart
T12	Procedure 299 321	sitting blood pressure
T13	Measurement 381 411	diastolic blood pressure (DBP)
T14	Value 412 420	=90 mmHg
T15	Measurement 424 453	systolic blood pressure (SBP)
T16	Value 454 463	=140 mmHg
T18	Temporal 101 110	currently
T22	Non-representable 464 510	(the second blood pressure was measured at V1)
T23	Person 544 549	woman
T24	Observation 553 569	childbearing age
T26	Qualifier 591 599	reliable
T27	Observation 600 620	contraceptive method
T28	Temporal 621 637	during the trial
T29	Reference_point 628 637	the trial
T30	Mood 575 588	agrees to use
T31	Observation 676 702	signed an informed consent
T32	Observation 643 667	Voluntarily participates
T33	Procedure 735 762	gene polymorphism detection
T34	Observation 795 817	genotype already known
T35	Qualifier 783 794	MTHFR C677T
T36	Qualifier 723 734	MTHFR C677T
T37	Condition 844 871	good tolerance to enalapril
T38	Drug 862 871	enalapril
T39	Measurement 881 910	overall medication compliance
T40	Value 876 880	good
T41	Value 912 916	>80%
T42	Temporal 938 948	previously
T43	Condition 959 973;988 1001	good tolerance to ACEI drugs
T44	Drug 991 1001	ACEI drugs
T45	Observation 959 963;978 1001	good adherence to ACEI drugs
T46	Temporal 1014 1032	medication history
T49	Observation 1050 1088	continues to participate in this study
T50	Qualifier 1038 1049	Voluntarily
